# Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride

> **NCT02007278** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 40 (actual)

## Conditions studied

- Type 2 Diabetes
- Hypoglycemia

## Interventions

- **DRUG:** vildagliptin and metformin (combination)
- **DRUG:** glimepiride
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02007278
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-03
- **Primary completion:** 2016-02-22
- **Final completion:** 2016-02-22
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007278, "Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02007278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*